The small GTPase RhoA controls activity of serum response factor (SRF) by inducing changes in actin dynamics. We show that in PC12 cells, activation of SRF after serum stimulation is RhoA dependent, requiring both actin polymerization and the Rho kinase (ROCK)–LIM kinase (LIMK)–cofilin signaling pathway, previously shown to control F-actin turnover. Activation of SRF by overexpression of wild-type LIMK or ROCK-insensitive LIMK mutants also requires functional RhoA, indicating that a second RhoA-dependent signal is involved. This is provided by the RhoA effector mDia: dominant interfering mDia1 derivatives inhibit both serum- and LIMK-induced SRF activation and reduce the ability of LIMK to induce F-actin accumulation. These results demonstrate a role for LIMK in SRF activation, and functional cooperation between RhoA-controlled LIMK and mDia effector pathways.
LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics
O. Geneste's present address is Division de Cancerologie, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy sur Seine, France.
Cancer Research UK London Research Institute comprises the Lincoln's Inn Fields and Clare Hall Laboratories of the former Imperial Cancer Research Fund (ICRF) after the merger of the ICRF with the Cancer Research Campaign in February, 2002.
Abbreviations used in this paper: 2D, two dimensional; LIMK, LIM kinase; MLC, myosin light chain; N-WASP, neural Wiskott-Aldrich Syndrome protein; ROCK, Rho kinase; SRF, serum response factor.
Olivier Geneste, John W. Copeland, Richard Treisman; LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics . J Cell Biol 28 May 2002; 157 (5): 831–838. doi: https://doi.org/10.1083/jcb.200203126
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement